Cargando…
Translating Tolerogenic Therapies to the Clinic – Where Do We Stand and What are the Barriers?
Autores principales: | Cobbold, Stephen P., Li, Xian C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469784/ https://www.ncbi.nlm.nih.gov/pubmed/23091475 http://dx.doi.org/10.3389/fimmu.2012.00317 |
Ejemplares similares
-
Translating tolerogenic therapies to the clinic – where do we stand?
por: Issa, Fadi, et al.
Publicado: (2012) -
Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
por: Marín, Eros, et al.
Publicado: (2018) -
Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016) -
Where Do We Stand?
Publicado: (1891) -
Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
por: Howie, Duncan, et al.
Publicado: (2014)